Boryung Pharm signs KRW 83 billion export agreement with Ram Pharma
Boryung Pharm made an official announcement that it has signed an export contract of KRW 83 billion for Todula with Jordanian Ram Pharma. Todula is a calcium channel blocker(CCB) antihypertensive.
The agreement with Ram Pharma, a Jordanian company, involves with the total USD 68,839,144, includi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.